Top 50 Medical Device Startup Investors in Germany (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
30 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $850k–$31M |
|
Bayern Kapital
VC Fund
|
12 | Germany, United States, Finland | Seed, Series A | Software, Health Care, Information Technology | $1.7M–$32M |
|
NRW.BANK
VC Fund
|
10 | Germany, United States, France | Seed, Series A, Series B | Information Technology, Software, Biotechnology | $219k–$71M |
|
TGFS - Technologiegründerfonds Sachsen
VC Fund
|
8 | Germany, United States | Seed, Series A | Software, Information Technology, Manufacturing | $796k–$15M |
|
KfW
VC Fund
|
7 | Germany, India, United Kingdom | Series A, Series B | Biotechnology, Software, Health Care | $2.2M–$17M |
|
bmp Ventures
VC Fund
|
7 | Germany, United States, Austria | Seed, Series A | Software, Information Technology, Manufacturing | $165k–$5.9M |
|
bm-t beteiligungsmanagement thuringen
VC Fund
|
7 | Germany, United States | Seed, Series A | Software, Health Care, Information Technology | $461k–$10M |
|
Brandenburg Kapital
VC Fund
|
6 | Germany, United Kingdom | Seed, Series A | Health Care, Software, Information Technology | $873k–$13M |
|
MIG Capital
VC Fund
|
5 | Germany, France, Austria | Series A, Series B, Seed | Biotechnology, Health Care, Software | $1.3M–$60M |
|
IFB Innovationsstarter
VC Fund
|
4 | Germany, United States | Seed, Grant | Software, SaaS, Artificial Intelligence | $79k–$3M |
|
HealthCap
VC Fund
|
4 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $6M–$92M |
|
European Investment Bank
VC Fund
|
4 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$636M |
|
Expon Capital
VC Fund
|
4 | Luxembourg, France, United States | Seed, Series A, Series B | Software, E-Commerce, FinTech | $527k–$102M |
|
Heal Capital
VC Fund
|
4 | Germany, United Kingdom, France | Seed, Series A, Pre-Seed | Health Care, Artificial Intelligence, Machine Learning | $1M–$35M |
|
TechVision Fund
VC Fund
|
4 | Germany, Spain | Seed, Series A, Pre-Seed | Software, Health Care, Manufacturing | $1.2M–$28M |
|
Born2Grow
VC Fund
|
3 | Germany, Finland, United States | Seed, Series A, Series B | Software, Medical, Health Care | $1.1M–$6M |
|
Rheingau Founders
VC Fund
|
3 | Germany, United States, Poland | Seed, Series A, Pre-Seed | Software, E-Commerce, Internet | $627k–$14M |
|
Sparrow Ventures
VC Fund
|
3 | Switzerland, Finland, Germany | Series A, Seed, Venture - Series Unknown | Health Care, Real Estate, Medical Device | $2.1M–$7.7M |
|
Think.Health
VC Fund
|
3 | Germany, United States, France | Seed, Series A, Series B | Health Care, Biotechnology, Medical Device | $1.1M–$28M |
|
MassMutual Ventures
VC Fund
|
3 | United States, India, Singapore | Series A, Series B, Seed | Software, Financial Services, Information Technology | $2.7M–$50M |
|
Playground Global
VC Fund
|
3 | United States, Canada, Italy | Series A, Series B, Seed | Software, Robotics, Biotechnology | $2.3M–$150M |
|
Seed Fonds Aachen
VC Fund
|
3 | Germany | Seed, Series A | Biotechnology, Medical, Software | $2.2M–$8M |
|
Hevella Capital
VC Fund
|
3 | Germany, Canada, Austria | Seed, Series A, Venture - Series Unknown | FinTech, Software, E-Commerce | $1.3M–$8.3M |
|
IBG Beteiligungsgesellschaft Sachsen-Anhalt
VC Fund
|
3 | Germany, Austria | Seed, Venture - Series Unknown, Series A | Medical Device, Software, Electronics | $1.3M–$13M |
|
Sofinnova Partners
VC Fund
|
3 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
TUDAG
VC Fund
|
3 | Germany | Seed, Pre-Seed, Series A | Electronics, Manufacturing, Sensor | $2.6M–$9.8M |
|
b2venture
VC Fund
|
3 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.4M–$52M |
|
Capacura
VC Fund
|
3 | Germany | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Recycling, Software | $505k–$2.9M |
|
SOSV
VC Fund
|
3 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
S-Venture Capital Dortmund
VC Fund
|
3 | Germany | Series B, Series A | Biotechnology, Guides, Genetics | $3.6M–$9M |
|
11k Ventures
VC Fund
|
3 | Germany, United States | Seed, Pre-Seed, Convertible Note | Software, Health Care, Medical Device | $674k–$3M |
|
YZR Capital
VC Fund
|
2 | Germany, Poland, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical, Software | $742k–$52M |
|
Rhein Invest
VC Fund
|
2 | Germany | Seed, Pre-Seed | SaaS, Medical, Software | |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
2 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
BayBG Venture Capital
VC Fund
|
2 | Germany, Italy, United States | Series A, Series B | Software, Information Technology, Health Care | $732k–$21M |
|
American RENOLIT Corporation
VC Fund
|
2 | Germany | Series A | Health Care, Medical Device, 3D Printing | $4M–$6M |
|
Taavet Hinrikus
Angel
|
2 | United Kingdom, United States, Estonia | Seed, Series A, Series B | FinTech, Software, Financial Services | $1.4M–$58M |
|
Monkfish Equity
VC Fund
|
2 | Germany, United States, Austria | Seed, Series A | Internet, E-Commerce, Marketplace | $475k–$15M |
|
LifeCare Partners
VC Fund
|
2 | Germany, Switzerland, United States | Series A, Post-IPO Equity | Biotechnology, Medical, Health Care | $4.1M–$20M |
|
BIF Partners
VC Fund
|
2 | Germany, Israel, Norway | Seed, Convertible Note, Pre-Seed | Health Care, Biotechnology, Therapeutics | $1.3M–$2M |
|
Cascara Ventures
VC Fund
|
2 | Germany, Finland, The Netherlands | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $2M–$7.9M |
|
Atlantic
VC Fund
|
2 | Germany, Switzerland, United States | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | $850k–$30M |
|
SARSTEDT
VC Fund
|
2 | Germany, Switzerland | Series A, Seed, Convertible Note | Medical Device, Wellness, Health Care | $6.1M–$6.4M |
|
The TQ Group
VC Fund
|
2 | Germany | Seed, Series A, Series B | Sports, Hardware, Robotics | |
|
Seventure Partners
VC Fund
|
2 | France, United States, Germany | Series A, Series B | Biotechnology, Health Care, Software | $3.3M–$63M |
|
APEX Ventures
VC Fund
|
2 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $552k–$28M |
|
Green Park & Golf Ventures
VC Fund
|
2 | United States, Israel, Sweden | Series A, Seed, Series B | Health Care, Medical, Biotechnology | $420k–$45M |
|
Sparkasse Jena
VC Fund
|
2 | Germany, United States | Seed, Series A, Series C | Medical, Health Care, Shopping | |
|
TruVenturo
VC Fund
|
2 | Germany, United States, Spain | Seed, Series A, Venture - Series Unknown | Travel, Tourism, Software | $1.1M–$45M |
|
Rolf Schromgens
Angel
|
2 | Germany, Spain, United States | Seed, Angel, Pre-Seed | Internet, Software, Education | $934k–$3.4M |
| Access all 381 investors in Germany Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 713
- Round size: Seed $850k–$6.9M; Series A $3.1M–$31M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $515M in 2022
Portfolio highlights
- Coredinate — COREDINATE is a fully integrated, professional and innovative solution for security companies, maintenance companies and care providers that helps optimize your processes, help you maintain your quality, and help you satisfy your customers. Whether it's control system, tour planning, task management or event capture: COREDINATE security ,maintenance or maintenance automates all your daily tasks and optimizes monitoring
- BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
- OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States, Finland
Investor stats
- Total investments: 252
- Round size: Seed $1.7M–$5.9M; Series A $4.1M–$32M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $29M in 2010
Portfolio highlights
- Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
- 4.screen — The Driver Interaction Platform. Connect with drivers in real-time to deliver personalized and targeted campaigns.
- inContAlert — inContAlert is a deep tech start-up disrupting the field of incontinence. The technology of inContAlert helps people with bladder dysfunction to monitor the filling level of their urinary bladder.inContAlert, therefore, developed an mHealth device, which collects and analyzes data with the help of deep learning algorithms. The information is thendisplayed on an app and sends an alert to incontinence patients when a predefined filling level is reached. inContAlert thereby minimizes the risk of an uncontrolled loss of urine or the harmful distension of the bladder. With the help of inContAlert, incontinence patients can go back to normal and live a carefree life.
NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
Show more...Investment focus
- Industry: Information Technology, Software, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, France
Investor stats
- Total investments: 134
- Round size: Seed $219k–$7.7M; Series A $2.4M–$36M; Series B $3.8M–$71M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — raised $163M in 2023
Portfolio highlights
- amber — info@amberoad.aiambeRoad is developing an intelligent enterprise search engine to help employees to find all relevant documents easily and quickly by integrating all company internal data sources into one search engine. Our solution allows access to all company-wide files from anywhere. Even if you don't exactly know what you are lookingfor, our cutting-edge AI will know because of a range of features implemented in our software.No need to tag documents manually, all in milliseconds - only one search request away.
- OMMM — OMMM Operations Management Solutions is a software house that specializes in the digitization and automation of industrial planning.
- ag-tech.systems — ag-tech.systems GmbH designs and manufactures tractor-mounted agricultural machinery that utilizes high-voltage electricity and a specialized conductive fluid to eliminate weeds and dry crops without synthetic chemicals. Their core value proposition centers on delivering a scalable, weather-independent alternative to chemical herbicides, enablingresidue-free harvesting and helping growers align with modern pesticide reduction regulations. The company monetizes its technology via outright machine sales, direct equipment rentals, and commercial leasing structures aimed at both private farmers and third-party service operators.
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 159
- Round size: Seed $796k–$4.8M; Series A $1.9M–$15M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Prodlane — Prodlane, the company behind MAIA, is a technology company based in Leipzig that specializes in intelligent software solutions for SMEs in the DACH region. With MAIA, we are setting new standards in data analysis and daily knowledge management in all areas of the company using AI, thereby driving forward the digital transformation of SMEs.
- Cyber Insight — Cyber Insight - Measure, Manage, Mitigate Cyber Risks
- HandsOn Robotics — Handson Robotics provides state of the art robotics automation workflows for commercial kitchens.
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Germany, India, United Kingdom
Investor stats
- Total investments: 162
- Round size: Series A $2.2M–$7.7M; Series B $3.3M–$17M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Andercore — Andercore connects global suppliers and local buyers on one AI-driven platform, automating inventory selection, pricing, quotes, financing and global distribution at scale.
- AtlasEdge — Empowering a sustainable digital society by enabling infrastructure where it is needed.
- Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.
bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States, Austria
Investor stats
- Total investments: 122
- Round size: Seed $165k–$3.6M; Series A $912k–$5.9M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fresh fund, raised $70M in 2024
Portfolio highlights
- Lab Thunder — LabThunder provides a cloud-based laboratory management software platform designed to digitize operational workflows. The system centers on centralizing equipment management, automated maintenance scheduling, digital logbooks, and AI-supported knowledge management to ensure audit-ready compliance.
- Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
- Solar Materials — Solar Materials primarily engages in the development of technologies for the sustainable and economical recycling of solar modules.
bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 72
- Round size: Seed $461k–$3.3M; Series A $1.2M–$10M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Altavo — Altavo operates as a medical device startup. Altavo harness the power of machine learning and state-of-the-art sensor technology to improve the lives of people who have lost their voice.
- Peeriot — Peeriot is a B2B software high-tech startup with a breakthrough in IoT. Peeriot offers a low-code software suite that simplifies IoT data sharing by tenfold.
- warmwind — warmwind is your all in one solution, when it comes to AI workers. No more tool chaos - everything in the cloud.
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United Kingdom
Investor stats
- Total investments: 80
- Round size: Seed $873k–$6.1M; Series A $2.8M–$13M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
- AssistMe — With a smart, adaptive and automated form of data processing and preparation, alea opens the way for future-proof, digitally supported everyday care. As an initial component of the AssistMe care platform, alea enables a contemporary, efficient care data culture for future intersectoral, networked processes and digitally supported teamwork. In theend, the aim is to effectively support care in times of a shortage of skilled workers through more self-determined content transparency - with complete personal autonomy and freedom of action and less redundancy & stress.Elderly Care will struggle in the next 10 years due to an increasing ageing population, fewer caregivers, more workload, stress, and manual documentation. All of that is a problem for the well-being of those in need of care. Furthermore, the incontinence management means large time and material expenses for caregivers. With the joint system, both companies can equip over 80 % of care recipients in care homes. An initial scientific study proved that the system could save 23 % of adult diapers and time while changing them. Together with significantly fewer leakages, the caregiver can reinvest the time gained in even higher quality care work. This ultimately has the potential to benefit care recipients in terms of quality of sleep and life. Digital functions for optimized care processesWith a very new smart sensor strip, we made leading quality adult diaper brands compatible with the digital possibilities of intelligent care technology of alea. The system reveals where care needs exist, but are not immediately visible, e.g. the urine status in the adult diaper which previously was not known until manually checked. The system transforms this initially hidden care and health data and converts it into digital, structured, immediately understandable real-time information for elderly care and its relevant stakeholders. All functionalities are based on the device alea sensor clip on smart Diaper products, which can be attached and changed in seconds. With just one quick click, caregivers turn the smart diaper into a ready-to-use digital care assistance system. With an optimal sensor position in the centre of the adult diaper and without direct skin contact. The alea hardware can generate highly valid information and make it available to care staff in real time through the mobile and web apps. The care-relevant information of alea includes the amount of urine, movements in the care bed for effective pressure ulcer prevention, fall detection and zone management. How caregivers, care homes & care recipients benefitOver 80 % of care home residents suffer from incontinence. This is a major challenge for everyone involved. The smart system solves issues for all care related audiences: Care recipients benefit from less time in full incontinence pads, but also benefit from fewer manual visual checks during bedtimes. In addition, there is a higher level of safety and prevention. By reducing time-consuming routine and visual checks on an as-needed basis. Caregivers can invest the time gained in other important or relevant care tasks. In this way, they can increase their self-determination in their work and thus their job satisfaction. Thanks to the significant savings in materials and costs, care home operators gain more planning security and can focus their business value creation even better on direct care for people in need of care. In this way, care homes can position themselves as more attractive employers for care staff because they have state-of-the-art digital equipment.With the Care. For the Care. The solution was developed and tested together with the care practice. With the IoT and future-proof platform approach, caregivers will benefit from additional functions in an established and accepted product setting. The system can be connected to various care documentation systems via open interfaces. The aim of the solution is not only to reduce the workload for all those involved in care. Care homes can also optimize teamwork and automate routine processes to support caregivers in the interests of people-centric care in the face of an increasing shortage of skilled staff. With the market entry, care homes can obtain information and order from us or one of our partners. While they order smart Diapers from our partners in the unit price context they are used to, alea Digital System comes as a software-as-a-service model. Without any additional initial costs, they can use all functions via personally provided hardware and software for each care recipient – for the most cost-efficient and needs-orientated use.
- All About Accuracy — Sub-1mm accuracy and <1ms latency RF localization for physical AI. Train robots with ground-truth motion data cameras and GPS can't reach.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B, Seed
- Geography: Germany, France, Austria
Investor stats
- Total investments: 98
- Round size: Seed $1.3M–$13M; Series A $2.2M–$40M; Series B $1.7M–$60M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $76M in 2014
Portfolio highlights
- NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
- GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
- Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Grant
- Geography: Germany, United States
Investor stats
- Total investments: 90
- Round size: Seed $365k–$3M; Grant $79k–$178k
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $16M in 2023
Portfolio highlights
- Flexvelop — Flexvelop is a fintech transforming the way businesses finance essential business equipment. "Flexing" is an innovative combination of leasing, renting and bank-financing terms offering a kind of Hardware-as-a-Service solution. Embedded as a payment solution, partnered manufacturers, vendors and brands are actively offering"Flexing" to their b2b customers for financing new business equipment right at the point of sale and in online shops. Flexvelop is operating in the verticals of office-it, hospitality equipment, medical devices or fitness equipment throughout Germany. Well-known manufacturers like Lenovo, WMF, or LaMarzocco are using Flexing openly or as a white-label solution. SMB customers flex equipment to grow flexibly without the usual investment risk – saving liquidity, tax and a clean balance sheet. Flexvelop is using its patented in-house financing technology, promoting a more sustainable circular economy in the same time. Flexing becomes the new standard for business equipment procurement for SMBs throughout Germany, Europe and beyond.
- Atrya — Atrya develops regulatory-compliant blockchain payments for international companies.
- DEALCIRCLE — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 140
- Round size: Series A $6M–$73M; Series B $12M–$92M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $179M in 2024
Portfolio highlights
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 571
- Round size: Post-IPO Debt $16M–$636M; Debt Financing $16M–$345M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Oceanloop — Oceanloop uses cutting-edge aquaculture technologies to transform the worldwide shrimp industry. Land-based Oceanloop shrimp farms provide high-quality, antibiotic-free, and sustainable saltwater shrimp production where consumption occurs. When compared to conventional farms, Oceanloop considerably reduces its resource utilization and environmentalfootprint.
- Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
Global investor in big ideas with the potential for positive impact & exponential growth
Show more...Investment focus
- Industry: Software, E-Commerce, FinTech
- Stage:Seed, Series A, Series B
- Geography: Luxembourg, France, United States
Investor stats
- Total investments: 129
- Round size: Seed $527k–$5M; Series A $2.2M–$34M; Series B $17M–$102M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $15M in 2023
Portfolio highlights
- Deelan — Save time and resources by training your team with Deelan's AI-native LMS. All-in-one platform for training performance of your teams, employees, partners, and customers. Create learning, grow skills and measure results in minutes.
- nexten.io — nexten.io is the leading subscription-free recruitment platform, connecting thousands of selected developers open to on site, remote or freelance opportunities with CTOs of the best tech companies across Europe.
- Service — Service gets you paid when your flight is delayed or cancelled.
Heal Capital is a European venture capital fund backing mission-driven founders with capital and HealthTech-specific expertise, accelerating market access.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, France
Investor stats
- Total investments: 50
- Round size: Seed $1M–$12M; Pre-Seed $1.9M–$4M; Series A $3.7M–$35M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
- Ditto — Ditto supports patients, loved ones, and professionals by improving clarity, recall, and communication in healthcare conversations.
- Tokura — Tokura focused on redesigning outpatient surgery (Ambulantes Operieren) through an integrated system of specialised facilities, experienced teams, and automated technology.
VF-Funds for innovative and scalable start-ups from the Rhineland Area, Germany
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Spain
Investor stats
- Total investments: 39
- Round size: Seed $2.4M–$5.8M; Pre-Seed $1.2M–$2.4M; Series A $5.4M–$28M
- Lead/follow: 67% lead, 33% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Octonomy — octonomy: AI-as-a-Service mit der neuen Generation von KI-Agenten. 80 % Zeitersparnis, 24/7-Support in 30+ Sprachen, live in 20 Tagen.
- Wakeline — Wakeline builds the missing half of AI: continual learning that adapts in operation, staying aligned as conditions change. Market Edge delivers adaptive day-ahead price forecasts for European BESS operators.
- specter automation — Construction is the second least digitized sector in the world with 96% of all data being unused. Although detailed planning data is created upfront, a lack of suitable digital tools prevents its transfer to the construction site. SPECTER’s web-based construction management software uniquely incorporates the core components of constructionplanning, reducing the organizational burden on construction management and helping to meet project timelines and budgets.
Born2Grow is a german venture fund focusing on early stage investments. They invest up to 500k€ in innovative business models. They are based in Heilbronn in Baden-Wuerttemberg. Born2Grow focus on investments lies within the MedTech, BioTech, FinTech area as well as some other online industries
Show more...Investment focus
- Industry: Software, Medical, Health Care
- Stage:Seed, Series A, Series B
- Geography: Germany, Finland, United States
Investor stats
- Total investments: 26
- Round size: Seed $1.1M–$6M; Series A $3M–$4.1M; Series B $1.1M–$3.3M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Semorai — Semorai - Intelligent error management for manufacturers We are reinventing the future of quality and error control in the industrial industry with our unique AI-as-a-Service solution.
- SpinDrive — SpinDrive technology increases efficiency by at least 15%. We provide tailored active magnetic bearing (AMB) systems for OEM's with competitive price.
- Unchained Robotics — Unchained Robotics engages in the development of artificial intelligence-based control system for robots for electronics production.
Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, Poland
Investor stats
- Total investments: 87
- Round size: Seed $627k–$6.3M; Pre-Seed $770k–$2.7M; Series A $2.7M–$14M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
- Qualifyze — Qualifyze (former ChemSquare) was founded out of the Technical University of Darmstadt in September 2017. Today, we are based in Frankfurt am Main, the heart of Germany’s pharmaceutical cluster, where the leading life science companies are based. Our team consists of 16 people with diverse backgrounds and areas of expertise in business,engineering, and technology as well as several strategic partners from the pharma, food and cosmetics industry.
- Akhetonics — Akhetonics is a photonic computing company building all-optical processors for ultra-fast AI and high-performance computing. It is a deep-tech semiconductor company focused on photonic (light-based) computing hardware. It develops all-optical processors designed to accelerate AI, reasoning, and complex computational workloads. The company aims todeliver ultra-fast, energy-efficient computing beyond traditional electronic chips.
We are a Zurich-based Venture Builder and Growth Equity Investor. With our ambitious team of highly customer-focused entrepreneurs, we are committed to putting our expertise to work and strive to make an impact.
Show more...Investment focus
- Industry: Health Care, Real Estate, Medical Device
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Switzerland, Finland, Germany
Investor stats
- Total investments: 15
- Round size: Seed $2.1M–$6.3M; Series A $3.6M–$7.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- properti — "building the world's greatest real estate company"Properti is a modern, young and pioneering PropTech startup founded in November 2019. Through our unique Properti System, which combines the latest technologies, in-depth expertise and world-class marketing, we provide an exclusive service. Our mission is to change the real estateindustry sustainably with the symbiosis of technology and people to build trustworthiness and transparency. Our goal is to offer customers a full service around the housing ecosystem.
- HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
- Selma Finance — With Selma you will get an investment plan that fits to your life and goals. Get started in minutes and let your money work for you.
Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, France
Investor stats
- Total investments: 36
- Round size: Seed $1.1M–$7.6M; Series A $3.8M–$28M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
- Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more...Investment focus
- Industry: Software, Financial Services, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, India, Singapore
Investor stats
- Total investments: 160
- Round size: Seed $2.7M–$11M; Series A $5M–$23M; Series B $7M–$50M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fresh fund, raised $150M in 2026
Portfolio highlights
- Versana — Centralized, real-time digital agent data unlocks end-to-end solutions across the $8T broadly syndicated loan and private credit markets.
- AGent Energy — AGent Energy operates a hardware and software platform that connects commercial, industrial, and institutional backup generators and other distributed energy resources to electricity markets. The company installs onsite equipment and software, monitors generator condition and utilization, and manages participation in demand-response and other gridprograms. Its platform supports remote dispatch, operational alerts, anomaly detection, compliance processes, and diagnostic data for facilities such as hospitals, manufacturers, data centers, universities, agricultural sites, retailers, and water infrastructure operators. AGent Energy shares market proceeds with participating facility owners while maintaining generator availability for backup use.
- EduFund — EduFund is India's leading education finance platform, helping parents plan, save, and pay for their child's higher education, in India or abroad. Co-founded in 2020 by Eela Dubey and Arindam Sengupta, EduFund was built on a simple conviction: most Indian families focus intensely on academic preparation for college and almost entirelyignore the financial side until it's too late. Eela Dubey, Co-founder and CEO, is a NYU graduate with a background in hedge funds on Wall Street. Arindam Sengupta, Co-founder, is a Princeton University alumnus with experience at Citadel and Reliance Capital. Together, they built EduFund to close the gap between being academically ready and financially ready for higher education. The platform offers a full suite of education finance tools, including mutual fund SIPs, fixed deposits, digital gold, and term insurance, alongside education loans, scholarship discovery, and end-to-end admissions support. Its AI-powered college cost calculator, Taara, gives parents inflation-adjusted cost estimates across 3,000+ colleges in 19+ countries in seconds, factoring in tuition, living costs, and currency risk. EduFund started out as a B2C app for consumers. EduFund's B2B platform, Vittam, serves to scale the same mission through India's MFD ecosystem, enabling wealth distributors to offer their clients a broader suite of financial products, from education loans and GIFT City funds to EB-5 global investment products and international health insurance. EduFund has served 250,000+ families and built a partner network of 40+ asset management firms and 15+ lending institutions, along with over 300 MFDs and IFA's through it's B2B vertical, Vittam. EduFund has raised $12 million in total funding, including a $6 million Series A led by Cercano Management and MassMutual Ventures. The company is also supported by angel investors.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Playground Global is an early-stage venture capital firm backing technical and scientific founders with deep engineering expertise, a collaborative environment, and a first-hand understanding of the intricacies of deep tech. Established in 2015 and headquartered in Palo Alto, CA, Playground’s mission is to transform ambitious ideas into impactfulbusinesses that benefit humanity and the planet. We invest in areas that span across next gen compute automation, energy transition and engineered biology. Playground has been an early – and frequently first investor – in companies that include PsiQuantum, Relativity Space, Ultima Genomics, MosaicML (acq. by Databricks), d-Matrix, and Strand Therapeutics.
Show more...Investment focus
- Industry: Software, Robotics, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Italy
Investor stats
- Total investments: 152
- Round size: Seed $2.3M–$14M; Series A $8M–$40M; Series B $20M–$150M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely actively investing — fresh fund, raised $475M in 2026
Portfolio highlights
- Infinimmune — Derived from human biology, engineered for human health. Infinimmune systematically surfaces and engineers the rare antibodies evolution has already proven in people and advances them into the clinic.
- Photon Queue — Photon storage solutions.
- Prazer Therapeutics — Prazer Therapeutics assists patients suffering from intractable diseases through the use of logical and innovative drug design approaches. They willaccomplished this through the use of new and innovative drug development platforms, such as rational molecular drug design technology and next-generation protein degradation technology.
Seed Fonds has a strong competence network with national and international investors, business angels & expertes from the industry. They are specialized in the development of comprehensive financing models offering stability and development opportunities on the long term.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Series A
- Geography: Germany
Investor stats
- Total investments: 19
- Round size: Series A $2.2M–$8M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Silexica — Silexica was a venture capital backed company for software development tools. The SLX programming tools accelerate the journey from software to application-specific hardware systems and thus reduce time-to-market of intelligent products.Founded in 2014 as a spin-off from RWTH Aachen University, Silexica was headquartered in Germany with officesin the US and Japan. It has received $28M in venture capital funding from international investors and was acquired by Xilinx/AMD in 2021.
- Cube Sports — Cube Sports operates kids, teens and adults sporting products.
- Vimecon — Vimecon develops and produces laser catheters for the treatment of heart diseases with a focus on atrial fibrillation. It also manufactures products for the medical technology and biotechnology; and offers microscopically small catheters, as well as micro materials handling techniques for exact measurement and dosage. Moreover, Vimecon advisesvarious customers from the scholar and industrial research and development. Kai U. Markus founded it in 2005, with its headquarters in Herzogenrath in Germany.
Hevella Capital is a principal investment firm.
Show more...Investment focus
- Industry: FinTech, Software, E-Commerce
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany, Canada, Austria
Investor stats
- Total investments: 22
- Round size: Seed $2.3M–$3.8M; Series A $4.1M–$7.7M; Venture - Series Unknown $1.3M–$8.3M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- fulfin — Beantragen Sie Ihre Finanzierung jetzt und wachsen Sie mit Fulfin!
- HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
- ChargeX — ChargeX provides electric car charging solutions. Tobias Wagner, Michael Masnitza, and Johannes Engeln founded it in 2017, with its headquarters in Munich in Germany.
IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.
Show more...Investment focus
- Industry: Medical Device, Software, Electronics
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Germany, Austria
Investor stats
- Total investments: 20
- Round size: Seed $1.3M–$3M; Series A $4.3M–$13M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $54M in 2017
Portfolio highlights
- RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
- Solar Materials — Solar Materials primarily engages in the development of technologies for the sustainable and economical recycling of solar modules.
- PerioTrap Pharmaceuticals GmbH — PerioTrap is an early stage biopharmaceutical company that aims to eradicate the root cause of periodontitis
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 348
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
The TUDAG group of the TU Dresden is a combination of past ten companies whose job it is to the knowledge of the university market. The aim is to encourage industry and in particular SMEs in the development of new technologies and innovative products. Also for the training of highly qualified staff provides the group TUDAG extensive benefits.Morethan 500 scientists, engineers, project managers and lecturers of the group realize TUDAG individual innovations across the entire value chain. Here, they work in interdisciplinary teams to work closely with scientists from the Technical University of Dresden and other scientific institutions.
Show more...Investment focus
- Industry: Electronics, Manufacturing, Sensor
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany
Investor stats
- Total investments: 12
- Round size: Seed $2.6M–$9.8M; Series A $3.5M–$5.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Altavo — Altavo operates as a medical device startup. Altavo harness the power of machine learning and state-of-the-art sensor technology to improve the lives of people who have lost their voice.
- Flexora — Flexora macht Anlagendigitalisierung einfach: Mit industrieller Sensorik erhalten Sie Echtzeitdaten und treffen datengetriebene Entscheidungen.
- Senorics — Material Sensing offers a way to identify and quantify materials quickly and easily. Its benefits are compelling and the possibilities it opens are broad.
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 266
- Round size: Seed $1.4M–$8.8M; Series A $4M–$23M; Series B $8M–$52M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fresh fund, raised $179M in 2026
Portfolio highlights
- Everlab — The preventative health service of the future. Detect disease early, improve wellbeing, and optimise performance.
- Flyboard — Human-level AI voice agents at a fraction of the cost. Transform your customer engagement with intelligent automation.
- Kiin Bio — Accelerate drug discovery with Virtual Scientists. Unified platform integrating 100+ specialized tools into one intelligent workflow.
Capacura is reinventing the venture capital market so that more start-ups get access to capital, knowledge, processes and solutions.
Show more...Investment focus
- Industry: Health Care, Recycling, Software
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Germany
Investor stats
- Total investments: 26
- Round size: Seed $505k–$2.9M; Pre-Seed $889k–$963k
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- odacova — Odacova is a SaaS company that provides individualized nutrition for corporate cafeterias and employee eating, utilizing web, Android, and iOS platforms.
- Foom — The foom technology extracts valuable fertiliser from organic waste - on site and in record time
- Everwave — Everwave is a social enterprise that focuses on preventing plastic pollution in rivers and oceans.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
S-Venture Capital Dortmund aims to fund technology companies and is a German regional investment group.
Show more...Investment focus
- Industry: Biotechnology, Guides, Genetics
- Stage:Series B, Series A
- Geography: Germany
Investor stats
- Total investments: 9
- Round size: Series B $3.6M–$9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Innolume — Innolume is a semiconductor laser fab for GaAs quantum dot and quantum well diode lasers, serving photonics, research and industrial projects.
- Protagen — Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address anumber of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases.The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
- Scienion — Provider of advanced biotech instruments, specializing in precision microdispensing and solutions for single-cell and 3D cellular model sorting and isolation.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We are a business angel collective based in Germany. We help early-stage startups that want to make a difference by preservation and improvement of human health.
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Germany, United States
Investor stats
- Total investments: 6
- Round size: Seed $674k–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- DeepSpin — DeepSpin is developing a next-gen, AI-powered MRI machine at a fraction of the cost, size and weight of standard systems, allowing to bring MRI to the point-of-care.
- Mindpeak — Harnessing the power of Artificial Intelligence and machine learning, Mindpeak products can help make pathology diagnosis faster and more accurate.
- atmio — atmio helps natural gas operations to find, fix and report methane emissions easily.
We back ambitious HealthTech founders solving complex healthcare challenges. We provide capital, deep sector expertise, and hands-on support to build global champions.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Poland, United Kingdom
Investor stats
- Total investments: 35
- Round size: Seed $2.6M–$5.5M; Pre-Seed $742k–$2.5M; Series A $10M–$52M
- Lead/follow: 63% lead, 37% follow
- Last fund: Likely still investing — raised $70M in 2022
Portfolio highlights
- Biorce — Biorce is an innovating HealthAI startup committed to transforming drug development through the use of artificial intelligence.
- dehaze — dehaze provides healthcare services by bringing medical AI models into clinical practice.
- Scripta Therapeutics — Biology decoded, disease undone - modulating transcription factors to restore health
We provide long-term capital in the German-Dutch market for SMEs with strong DNA
Show more...Investment focus
- Industry: SaaS, Medical, Software
- Stage:Seed, Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- CUREosity — CUREosity has the vision to revolutionize traditional rehabilitation by developing VR-based therapy applications and games to help people with neurological and mental disabilities.To do so, CUREosity provides the CE-certified medical product CUREO, which is a therapy system to support the cognitive, sensory, and motor rehabilitation. Theimmersion in new worlds with different scenarios and game elements motivates patients to high-frequency training and thus to fast therapy success. With CUREO, multiple patients can be cared for by just one therapist, so that clinic resources can be optimally allocated.Thomas Saur, Stefan Arand and Marco Faulhammer founded CUREosity on November 26, 2018 in Düsseldorf.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 107
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 49% lead, 51% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- TECregen — TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.
Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Series B
- Geography: Germany, Italy, United States
Investor stats
- Total investments: 118
- Round size: Series A $1.2M–$6.4M; Series B $732k–$21M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- socialhub — Boost your social media success with SocialHub. Manage channels, schedule posts & get meaningful analytics. Try it out now!
- SPiNE — SPiNE is a startup that provides safe, clean, and inexpensive energy to all end users. It is focused on smart meter rollout and, as a result, digitalization in metering and control of charging infrastructure, heat pumps, and battery storage.
- TalentRocket — Talent Rocket is a job search engine that enables its users to find jobs with a suitable work environment for them. Job seekers can select their preferred company culture, follow their favorite companies, and start career conversations with employers. Talent Rocket was founded in 2014 and is based in London, United Kingdom.
With decorative, high-quality and sustainable plastic products, we create clear added value for our customers and improve the quality of life.
Show more...Investment focus
- Industry: Health Care, Medical Device, 3D Printing
- Stage:Series A
- Geography: Germany
Investor stats
- Total investments: 2
- Round size: Series A $4M–$6M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Kumovis — The EXT 220 MED, formerly the Kumovis R1, is the only extrusion platform that features an integrated clean room and is validated by leading medical device manufacturers and hospitals worldwide.
- Inovedis — The SINEFIX Implant System is an easy-to-learn solution aimed at simplifying rotator cuff repair procedures and improving patient outcomes.
Taavet Hinrikus is based out of London, England and is the Partner of Plural Platform and Board Member of CoMind. Taavet previously worked at Wise as a Chairman and Co-founder. Taavet Hinrikus attended INSEAD.
Show more...Investment focus
- Industry: FinTech, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Estonia
Investor stats
- Total investments: 135
- Round size: Seed $1.4M–$10M; Series A $6.4M–$45M; Series B $23M–$58M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Lassie — AI that runs the doctor's office.
- Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
- Lightyear — Lightyear is a simple and approachable way to invest your money globally without unnecessary barriers and fees.
Monkfish Equity is the investment vehicle of the trivago founders. TRVG was started in 2004 and went IPO with over 1 b$ in revenue on NASDAQ in 2016. It was then labelled one of the first real Unicorns in Germany. As Co-investors, with a focus on later stage phases, they invest in companies which can benefit from their entrepreneurial experience.As “low maintenance” investors, they offer the leeway that entrepreneurs need to build their businesses. So far, the Monkfish team has invested in over 50 start-ups in Europe, Asia, the US and South Africa.
Show more...Investment focus
- Industry: Internet, E-Commerce, Marketplace
- Stage:Seed, Series A
- Geography: Germany, United States, Austria
Investor stats
- Total investments: 56
- Round size: Seed $475k–$3M; Series A $3.3M–$15M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Dogo — Dogo app - dog trainer in your pocket. Strengthen your friendship with training
- Refurbed — Refurbed operates as an online marketplace for refurbished products in the german-speaking world. It sells renewed phones, laptops and tablets which are up to 40% cheaper and 100% more environmentally friendly than their brand-new, store-bought counterparts. Refurbed devices are renewed through a 40-step process, making them look like new andfunction like new. On top of that, each device comes with at least a 12-month guarantee.The company was founded in 2017 and is headquartered in Vienna, Austria.
- ArtNight GmbH — ArtNight GmbH offers unique do-it-yourself art workshops.
LifeCare Partners provides private equity and mezzanine financing
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Post-IPO Equity
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 11
- Round size: Series A $4.1M–$20M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- b-rayZ — Optimize and streamline your breast imaging workflow with AI excellence and precision from b-rayZ. Your trusted partner in breast diagnostics.
- Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
- NeoPrediX — NeoPrediX develops decision support tools with maternal, neonatal and perinatal screening platforms to evaluate, optimize and personalize medical strategies in pediatrics. We utilize intelligent algorithms and digital health solutions for neonatal and perinatal care based on deep medical data and science, developed by experienced scientists,pediatricians, and neonatologists. We transform medical data into intelligent predictions to support clinical decisions.
Angel Investors focusing on Seed Investments
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: Germany, Israel, Norway
Investor stats
- Total investments: 14
- Round size: Seed $1.3M–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hemispherian — Hemispherian is an innovative preclinical pharmaceutical company focused on developing a novel class of small molecule drugs. These drugs target the TET2 enzyme as an epigenetic therapy for particularly aggressive cancers.
- ECO Group — Eco is a supplier of consumer products. They create structures for increased growth and profitability within the group companies.
- Lucid Genomics — Lucid Genomics is an AI-powered platform that focuses on diagnostics and biomarker detection. It offer comprehensive DNA analysis, that includes coding and non-coding mutation prioritization and interpretation.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!96 Normal 0 false false false EN-GB X-NONE X-NONE
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: Germany, Finland, The Netherlands
Investor stats
- Total investments: 13
- Round size: Series A $2M–$7.9M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Fiagon — Fiagon develops clinical navigation systems that reimagine image guidance by improving the function of electromagnetic navigation. Fiagon's systems use electromagnetic tracking matrix algorithms and flexible pointer technology that indicates the position of the instrument used in the CT or MRI image data, allowing physicians to get accurateplanning, improve patient outcomes, and implementation of the operation.
- Meidrix Biomedicals — Meidrix Biomedicals is a medical biotechnology company that specializes in medical devices for cartilage repair. Meidrix Biomedicals also offers regenerative and biological medical products. Meidrix Biomedicals was founded in 2009 and was headquartered in Bayern, Germany.
- SurgicEye — SurgicEye designs intra-operative imaging and instrument navigation solutions for surgical procedures. It offers a navigated radio-guided surgery based on the handheld 3-D freehand SPECT imaging technology called the declipse SPECT open surgery, an intraoperative 3D imaging system for invasive sentinel lymph node biopsy called the declipse SPECTLaparascopy, and a mobile SPECT imaging solution with a high resolution on a small footprint called the declipse SPECT imaging probe. The company also advises clients on medical device development, requirement engineering and software specification for medical devices, software development for medical devices, testing of software for medical devices, and support in the design and conduction of clinical studies.Dr. Jörg Traub founded SurgicEye in 2008, with its headquarters in Munich in Germany.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 257
- Round size: Seed $1.2M–$9.4M; Pre-Seed $850k–$3.5M; Series A $4.6M–$30M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $110M in 2022
Portfolio highlights
- Stenon — Stenon is a laboratory independent real-time soil analyst that offers solutions for agriculture.
- 42matters — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
- NewOrbit Space — NewOrbit Space is a satellite manufacturing company. We engineer Earth's lowest orbiting satellites, at altitudes of 180km (3x lower than conventional LEO satellites) we enable better imagery resolution and telecommunication services from space.
Sarstedt, one of the world's leading providers of laboratory and medical equipment, develops, manufactures and sells equipment and consumables in the field of medicine and science.
Show more...Investment focus
- Industry: Medical Device, Wellness, Health Care
- Stage:Series A, Seed, Convertible Note
- Geography: Germany, Switzerland
Investor stats
- Total investments: 4
- Round size: Series A $6.1M–$6.4M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- faCellitate — faCellitate develops polymeric platforms that aim at supporting cancer and stem cell research, drug discovery, toxicology, and tissue engineering. The platform facilitates cellular interaction, significantly improving cell culture in biological research.
- Loop Medical — Loop Medical is on a mission to develop an easy and painless blood collection technology making it accessible to all.
- Smart4Diagnostics — Smart4Diagnostics is a manufacturer of a device for blood sample measurement.
TQ Group is one of the leading technology companies in the electronics industry, offering a complete range of services
Show more...Investment focus
- Industry: Sports, Hardware, Robotics
- Stage:Seed, Series A, Series B
- Geography: Germany
Investor stats
- Total investments: 7
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- enna — enna is the window to the digital world for people who have problems using smartphones or tablets
- Mellow Boards — Independent editorial archive documenting Mellow Boards history, modular electric drive technology, founders, and Kickstarter story from Hamburg.
- Reactive Robotics — Reactive Robotics was founded as a GmbH in Munich, Germany, in April 2015. Their team has a combined 12 years of rehabilitation robotics research, vast startup experience and a large clinical network to bring this device to life. They are proud to feature an excellent array of supporters that provide advice on every level required for thesuccessful start-up of a medical technology company. Confirmed advisors provide access to patients, support them in engineering, on legal issues and when dealing with the details of registering a medical device with the authorities.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B
- Geography: France, United States, Germany
Investor stats
- Total investments: 258
- Round size: Series A $3.3M–$28M; Series B $3.4M–$63M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Flexvelop — Flexvelop is a fintech transforming the way businesses finance essential business equipment. "Flexing" is an innovative combination of leasing, renting and bank-financing terms offering a kind of Hardware-as-a-Service solution. Embedded as a payment solution, partnered manufacturers, vendors and brands are actively offering"Flexing" to their b2b customers for financing new business equipment right at the point of sale and in online shops. Flexvelop is operating in the verticals of office-it, hospitality equipment, medical devices or fitness equipment throughout Germany. Well-known manufacturers like Lenovo, WMF, or LaMarzocco are using Flexing openly or as a white-label solution. SMB customers flex equipment to grow flexibly without the usual investment risk – saving liquidity, tax and a clean balance sheet. Flexvelop is using its patented in-house financing technology, promoting a more sustainable circular economy in the same time. Flexing becomes the new standard for business equipment procurement for SMBs throughout Germany, Europe and beyond.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 61
- Round size: Seed $1.4M–$8M; Pre-Seed $552k–$9.1M; Series A $5.7M–$28M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- Jago Coffee — Jago Coffee serves freshly brewed coffee beverages wherever you are through a fleet of fully electric mobile cafes.
Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Sweden
Investor stats
- Total investments: 94
- Round size: Seed $420k–$3.2M; Series A $1.3M–$18M; Series B $2.1M–$45M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Vellum Health — Vellum Health platform provides on-demand IV enablement & treatment optimized for provider organizations, payers, clinicians, and patients.
- Affineon Health — Affineon is the AI inbox that saves provider time. We automatically handle normal and clinically insignificant lab results, and help providers get through abnormal lab results faster. Our AI automatically groups, analyzes, and trends lab results into a smart summary, including possible next steps and a complete patient note. We also route"noise" to staff, reducing the number of messages a physician needs to pay attention to by up to 30%. The result is 5+ hours saved per week per provider. Plus, Affineon tightly integrates with the EHR, so providers don’t need to change their existing workflow.
- Mobia Medical — MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and variousneurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues.Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.
Sparkasse Jena is a German savings bank offers a collection of financial products and services to private, retail, and corporate customers.
Show more...Investment focus
- Industry: Medical, Health Care, Shopping
- Stage:Seed, Series A, Series C
- Geography: Germany, United States
Investor stats
- Total investments: 7
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- NovaPump — The NovaPump GmbH is a cardiology company based in Jena/Germany devoloping cutting-edge therapeutical solutions in the field of non-invasive and percutaneous circulation support. The so called PERKAT (PERKutane KATheterpumpe) technique will be offered as pLVAD & pRVAD heart pumps for acute left or right heart patients within the nextyears. PERKAT works together with the current IABP technique (intra aortic balloon pump with about 200,000 cases p.a. internationally) and is the only-one catheter-based & self-expanding, pulsatile & ECG-triggered, cost-effective heart pump technique with a high pump performance. PERKAT is not available on the market so far. Articles in leading scientific journals and presentations at the top four international cardiology conferences in the last years show the medical need, the development status and the technological and medical advantages of PERKAT.
- PERCEPTEC — PERCEPTEC is an application-oriented think tank with the aim of accelerating the process of modernization and digitalization of the optometric and ophthalmological sector.
- DeepEn — DeepEn is a research transfer start-up from Leibniz Institute of Photonic Technologies. It focus on the development of solutions in the field of fibrephotonics, biophotonics and bioimaging.
TruVenturo is an entrepreneurial investor and company builder in Europe and the United States
Show more...Investment focus
- Industry: Travel, Tourism, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany, United States, Spain
Investor stats
- Total investments: 19
- Round size: Seed $1.1M–$24M; Series A $2.4M–$20M; Venture - Series Unknown $12M–$45M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Rune Labs — Software and data platform for neuromodulation
- get.me — get.me connects social media accounts or links to sites. They create a free link in their bio page that earns money and turns followers into paying subscribers, so they earn money from social media with every subscriber.
- Tomorrow Bio — At Tomorrow Bio, we use the latest technology to preserve you for however long it takes until medical technology can extend your life.
Rolf Schromgens - Co-Founder @ leadership.sprouts
Show more...Investment focus
- Industry: Internet, Software, Education
- Stage:Seed, Angel, Pre-Seed
- Geography: Germany, Spain, United States
Investor stats
- Total investments: 28
- Round size: Seed $934k–$3.4M; Pre-Seed $1.2M–$1.4M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- socialbnb — Explore sustainable travel with socialbnb. Book sustainable accommodations, hotels, b&bs, experiences and trips that support local communities. Travel with social impact. Discover now!
- Teech Education — Teech Education is a platform for schools to enable digital teaching.
- CODE University of Applied Sciences — CODE is a Berlin-based state-accredited university of applied sciences that offers bachelor’s degree programs in the field of Digital Product Development.
Medical Device Investor funding in Germany at a glance
Stats across 367 deals from 381 investors.
Access all 381 investors in Germany Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 381 investors investing in Germany Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!